Lynn M. Matrisian - Publications

Vanderbilt University, Nashville, TN 
Cell Biology, Oncology

30/99 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Samuelson LE, Scherer RL, VanSaun MN, Fan KH, Dozier EA, Carter KJ, Koyama T, Shyr Y, Aschner M, Stanwood GD, Bornhop DJ, Matrisian LM, McIntyre JO. New tools for the quantitative assessment of prodrug delivery and neurotoxicity. Neurotoxicology. 47: 88-98. PMID 25732874 DOI: 10.1016/j.neuro.2015.02.005  0.68
2013 Samuelson LE, Scherer RL, Matrisian LM, McIntyre JO, Bornhop DJ. Synthesis and in vitro efficacy of MMP9-activated NanoDendrons. Molecular Pharmaceutics. 10: 3164-74. PMID 23750801 DOI: 10.1021/mp4002206  0.68
2013 Lee IK, Vansaun MN, Shim JH, Matrisian LM, Gorden DL. Increased metastases are associated with inflammation and matrix metalloproteinase-9 activity at incision sites in a murine model of peritoneal dissemination of colorectal cancer. The Journal of Surgical Research. 180: 252-9. PMID 22763216 DOI: 10.1016/j.jss.2012.04.074  0.36
2012 Thiolloy S, Edwards JR, Fingleton B, Rifkin DB, Matrisian LM, Lynch CC. An osteoblast-derived proteinase controls tumor cell survival via TGF-beta activation in the bone microenvironment. Plos One. 7: e29862. PMID 22238668 DOI: 10.1371/journal.pone.0029862  0.36
2011 Gorden DL, Ivanova PT, Myers DS, McIntyre JO, VanSaun MN, Wright JK, Matrisian LM, Brown HA. Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model. Plos One. 6: e22775. PMID 21857953 DOI: 10.1371/journal.pone.0022775  0.68
2010 Lynch CC, Vargo-Gogola T, Matrisian LM, Fingleton B. Cleavage of E-Cadherin by Matrix Metalloproteinase-7 Promotes Cellular Proliferation in Nontransformed Cell Lines via Activation of RhoA. Journal of Oncology. 2010: 530745. PMID 20628524 DOI: 10.1155/2010/530745  0.36
2010 Uddin MJ, Crews BC, Blobaum AL, Kingsley PJ, Gorden DL, McIntyre JO, Matrisian LM, Subbaramaiah K, Dannenberg AJ, Piston DW, Marnett LJ. Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agents. Cancer Research. 70: 3618-27. PMID 20430759 DOI: 10.1158/0008-5472.CAN-09-2664  0.68
2010 McIntyre JO, Scherer RL, Matrisian LM. Near-infrared optical proteolytic beacons for in vivo imaging of matrix metalloproteinase activity. Methods in Molecular Biology (Clifton, N.J.). 622: 279-304. PMID 20135290 DOI: 10.1007/978-1-60327-299-5_18  0.68
2009 McIntyre JO, Matrisian LM. Optical proteolytic beacons for in vivo detection of matrix metalloproteinase activity. Methods in Molecular Biology (Clifton, N.J.). 539: 155-74. PMID 19377965 DOI: 10.1007/978-1-60327-003-8_9  0.68
2008 Scherer RL, VanSaun MN, McIntyre JO, Matrisian LM. Optical imaging of matrix metalloproteinase-7 activity in vivo using a proteolytic nanobeacon. Molecular Imaging. 7: 118-31. PMID 19123982  0.68
2008 Martin MD, Fingleton B, Lynch CC, Wells S, McIntyre JO, Piston DW, Matrisian LM. Establishment and quantitative imaging of a 3D lung organotypic model of mammary tumor outgrowth. Clinical & Experimental Metastasis. 25: 877-85. PMID 18787962 DOI: 10.1007/s10585-008-9206-y  0.68
2008 Quarles CC, Lepage M, Gorden DL, Fingleton B, Yankeelov TE, Price RR, Matrisian LM, Gore JC, McIntyre JO. Functional colonography of Min mice using dark lumen dynamic contrast-enhanced MRI. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 60: 718-26. PMID 18727087 DOI: 10.1002/mrm.21724  0.68
2008 Martin MD, Carter KJ, Jean-Philippe SR, Chang M, Mobashery S, Thiolloy S, Lynch CC, Matrisian LM, Fingleton B. Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background. Cancer Research. 68: 6251-9. PMID 18676849 DOI: 10.1158/0008-5472.CAN-08-0537  0.36
2008 Scherer RL, McIntyre JO, Matrisian LM. Imaging matrix metalloproteinases in cancer. Cancer Metastasis Reviews. 27: 679-90. PMID 18465089 DOI: 10.1007/s10555-008-9152-9  0.68
2007 Lepage M, Dow WC, Melchior M, You Y, Fingleton B, Quarles CC, Pépin C, Gore JC, Matrisian LM, McIntyre JO. Noninvasive detection of matrix metalloproteinase activity in vivo using a novel magnetic resonance imaging contrast agent with a solubility switch. Molecular Imaging. 6: 393-403. PMID 18053410 DOI: 10.2310/7290.2007.00035  0.68
2007 Lynch CC, Vargo-Gogola T, Martin MD, Fingleton B, Crawford HC, Matrisian LM. Matrix metalloproteinase 7 mediates mammary epithelial cell tumorigenesis through the ErbB4 receptor. Cancer Research. 67: 6760-7. PMID 17638887 DOI: 10.1158/0008-5472.CAN-07-0026  0.36
2007 Schwartz DR, Moin K, Yao B, Matrisian LM, Coussens LM, Bugge TH, Fingleton B, Acuff HB, Sinnamon M, Nassar H, Platts AE, Krawetz SA, Linebaugh BE, Sloane BF. Hu/Mu ProtIn oligonucleotide microarray: dual-species array for profiling protease and protease inhibitor gene expression in tumors and their microenvironment. Molecular Cancer Research : McR. 5: 443-54. PMID 17510311 DOI: 10.1158/1541-7786.MCR-06-0337  0.36
2006 Halpern J, Lynch CC, Fleming J, Hamming D, Martin MD, Schwartz HS, Matrisian LM, Holt GE. The application of a murine bone bioreactor as a model of tumor: bone interaction. Clinical & Experimental Metastasis. 23: 345-56. PMID 17136574 DOI: 10.1007/s10585-006-9044-8  0.36
2006 Acuff HB, Sinnamon M, Fingleton B, Boone B, Levy SE, Chen X, Pozzi A, Carbone DP, Schwartz DR, Moin K, Sloane BF, Matrisian LM. Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancer. Cancer Research. 66: 7968-75. PMID 16912171 DOI: 10.1158/0008-5472.CAN-05-4279  0.36
2006 Menon R, McIntyre JO, Matrisian LM, Fortunato SJ. Salivary proteinase activity: a potential biomarker for preterm premature rupture of the membranes. American Journal of Obstetrics and Gynecology. 194: 1609-15; discussion . PMID 16731078 DOI: 10.1016/j.ajog.2006.02.052  0.68
2006 VanSaun MN, Matrisian LM. Matrix metalloproteinases and cellular motility in development and disease. Birth Defects Research. Part C, Embryo Today : Reviews. 78: 69-79. PMID 16622849 DOI: 10.1002/bdrc.20061  0.36
2006 Acuff HB, Carter KJ, Fingleton B, Gorden DL, Matrisian LM. Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment. Cancer Research. 66: 259-66. PMID 16397239 DOI: 10.1158/0008-5472.CAN-05-2502  0.36
2005 Lynch CC, Hikosaka A, Acuff HB, Martin MD, Kawai N, Singh RK, Vargo-Gogola TC, Begtrup JL, Peterson TE, Fingleton B, Shirai T, Matrisian LM, Futakuchi M. MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell. 7: 485-96. PMID 15894268 DOI: 10.1016/j.ccr.2005.04.013  0.36
2005 Kundranda MN, Henderson M, Carter KJ, Gorden L, Binhazim A, Ray S, Baptiste T, Shokrani M, Leite-Browning ML, Jahnen-Dechent W, Matrisian LM, Ochieng J. The serum glycoprotein fetuin-A promotes Lewis lung carcinoma tumorigenesis via adhesive-dependent and adhesive-independent mechanisms. Cancer Research. 65: 499-506. PMID 15695392  0.48
2005 Harrell PC, McCawley LJ, Fingleton B, McIntyre JO, Matrisian LM. Proliferative effects of apical, but not basal, matrix metalloproteinase-7 activity in polarized MDCK cells. Experimental Cell Research. 303: 308-20. PMID 15652345 DOI: 10.1016/j.yexcr.2004.09.020  0.68
2004 Fingleton B, Menon R, Carter KJ, Overstreet PD, Hachey DL, Matrisian LM, McIntyre JO. Proteinase activity in human and murine saliva as a biomarker for proteinase inhibitor efficacy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 7865-74. PMID 15585619 DOI: 10.1158/1078-0432.CCR-04-1252  0.68
2004 Wagenaar-Miller RA, Gorden L, Matrisian LM. Matrix metalloproteinases in colorectal cancer: is it worth talking about? Cancer Metastasis Reviews. 23: 119-35. PMID 15000153  0.48
2004 McIntyre JO, Fingleton B, Wells KS, Piston DW, Lynch CC, Gautam S, Matrisian LM. Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity. The Biochemical Journal. 377: 617-28. PMID 14556651 DOI: 10.1042/BJ20030582  0.68
2003 McIntyre JO, Matrisian LM. Molecular imaging of proteolytic activity in cancer. Journal of Cellular Biochemistry. 90: 1087-97. PMID 14635184 DOI: 10.1002/jcb.10713  0.68
2003 Wagenaar-Miller RA, Hanley G, Shattuck-Brandt R, DuBois RN, Bell RL, Matrisian LM, Morgan DW. Cooperative effects of matrix metalloproteinase and cyclooxygenase-2 inhibition on intestinal adenoma reduction. British Journal of Cancer. 88: 1445-52. PMID 12778076 DOI: 10.1038/sj.bjc.6600867  0.48
Low-probability matches
2010 Martin MD, Kremers GJ, Short KW, Rocheleau JV, Xu L, Piston DW, Matrisian LM, Gorden DL. Rapid extravasation and establishment of breast cancer micrometastases in the liver microenvironment. Molecular Cancer Research : McR. 8: 1319-27. PMID 20724460 DOI: 10.1158/1541-7786.MCR-09-0551  0.28
2008 Sinnamon MJ, Carter KJ, Fingleton B, Matrisian LM. Matrix metalloproteinase-9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse. International Journal of Experimental Pathology. 89: 466-75. PMID 19134056 DOI: 10.1111/j.1365-2613.2008.00621.x  0.28
2008 McCawley LJ, Wright J, LaFleur BJ, Crawford HC, Matrisian LM. Keratinocyte expression of MMP3 enhances differentiation and prevents tumor establishment. The American Journal of Pathology. 173: 1528-39. PMID 18832569 DOI: 10.2353/ajpath.2008.080132  0.28
2008 Sinnamon MJ, Carter KJ, Sims LP, Lafleur B, Fingleton B, Matrisian LM. A protective role of mast cells in intestinal tumorigenesis. Carcinogenesis. 29: 880-6. PMID 18258601 DOI: 10.1093/carcin/bgn040  0.28
2007 Fingleton B, Carter KJ, Matrisian LM. Loss of functional Fas ligand enhances intestinal tumorigenesis in the Min mouse model. Cancer Research. 67: 4800-6. PMID 17510409 DOI: 10.1158/0008-5472.CAN-06-4473  0.28
2007 Gorden DL, Fingleton B, Crawford HC, Jansen DE, Lepage M, Matrisian LM. Resident stromal cell-derived MMP-9 promotes the growth of colorectal metastases in the liver microenvironment. International Journal of Cancer. 121: 495-500. PMID 17417772 DOI: 10.1002/ijc.22594  0.28
2007 Nicoud IB, Jones CM, Pierce JM, Earl TM, Matrisian LM, Chari RS, Gorden DL. Warm hepatic ischemia-reperfusion promotes growth of colorectal carcinoma micrometastases in mouse liver via matrix metalloproteinase-9 induction. Cancer Research. 67: 2720-8. PMID 17363593 DOI: 10.1158/0008-5472.CAN-06-3923  0.28
2007 Fingleton B, Powell WC, Crawford HC, Couchman JR, Matrisian LM. A rat monoclonal antibody that recognizes pro- and active MMP-7 indicates polarized expression in vivo. Hybridoma (2005). 26: 22-7. PMID 17316082 DOI: 10.1089/hyb.2006.028  0.28
2006 Buchanan FG, Gorden DL, Matta P, Shi Q, Matrisian LM, DuBois RN. Role of beta-arrestin 1 in the metastatic progression of colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America. 103: 1492-7. PMID 16432186 DOI: 10.1073/pnas.0510562103  0.28
2005 Chen X, Su Y, Fingleton B, Acuff H, Matrisian LM, Zent R, Pozzi A. An orthotopic model of lung cancer to analyze primary and metastatic NSCLC growth in integrin alpha1-null mice. Clinical & Experimental Metastasis. 22: 185-93. PMID 16086239 DOI: 10.1007/s10585-005-7453-8  0.28
2005 Chen X, Su Y, Fingleton B, Acuff H, Matrisian LM, Zent R, Pozzi A. Increased plasma MMP9 in integrin alpha1-null mice enhances lung metastasis of colon carcinoma cells. International Journal of Cancer. 116: 52-61. PMID 15756690 DOI: 10.1002/ijc.20997  0.28
2004 Yang L, DeBusk LM, Fukuda K, Fingleton B, Green-Jarvis B, Shyr Y, Matrisian LM, Carbone DP, Lin PC. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell. 6: 409-21. PMID 15488763 DOI: 10.1016/j.ccr.2004.08.031  0.28
2004 McCawley LJ, Crawford HC, King LE, Mudgett J, Matrisian LM. A protective role for matrix metalloproteinase-3 in squamous cell carcinoma. Cancer Research. 64: 6965-72. PMID 15466188 DOI: 10.1158/0008-5472.CAN-04-0910  0.28
2004 Gustavson MD, Crawford HC, Fingleton B, Matrisian LM. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters. Molecular Carcinogenesis. 41: 125-39. PMID 15457508 DOI: 10.1002/mc.20049  0.28
2004 Mohammed FF, Smookler DS, Taylor SE, Fingleton B, Kassiri Z, Sanchez OH, English JL, Matrisian LM, Au B, Yeh WC, Khokha R. Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nature Genetics. 36: 969-77. PMID 15322543 DOI: 10.1038/ng1413  0.28
2004 Leite-Browning ML, McCawley LJ, Jahnen-Dechent W, King LE, Matrisian LM, Ochieng J. Alpha 2-HS glycoprotein (fetuin-A) modulates murine skin tumorigenesis. International Journal of Oncology. 25: 319-24. PMID 15254728  0.28
2004 Hulboy DL, Gautam S, Fingleton B, Matrisian LM. The influence of matrix metalloproteinase-7 on early mammary tumorigenesis in the multiple intestinal neoplasia mouse. Oncology Reports. 12: 13-7. PMID 15201952  0.28
2002 Vargo-Gogola T, Crawford HC, Fingleton B, Matrisian LM. Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand. Archives of Biochemistry and Biophysics. 408: 155-61. PMID 12464266  0.28
2002 Leite-Browning ML, McCawley LJ, Choi OH, Matrisian LM, Ochieng J. Interactions of alpha2-HS-glycoprotein (fetuin) with MMP-3 and murine squamous cell carcinoma cells. International Journal of Oncology. 21: 965-71. PMID 12370742  0.28
2002 Vargo-Gogola T, Fingleton B, Crawford HC, Matrisian LM. Matrilysin (matrix metalloproteinase-7) selects for apoptosis-resistant mammary cells in vivo. Cancer Research. 62: 5559-63. PMID 12359768  0.28
2002 Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science (New York, N.Y.). 295: 2387-92. PMID 11923519 DOI: 10.1126/science.1067100  0.28
2001 Crawford HC, Fingleton B, Gustavson MD, Kurpios N, Wagenaar RA, Hassell JA, Matrisian LM. The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors. Molecular and Cellular Biology. 21: 1370-83. PMID 11158322 DOI: 10.1128/MCB.21.4.1370-1383.2001  0.28
2014 Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Research. 74: 2913-21. PMID 24840647 DOI: 10.1158/0008-5472.CAN-14-0155  0.2
2013 Hoos WA, James PM, Rahib L, Talley AW, Fleshman JM, Matrisian LM. Pancreatic cancer clinical trials and accrual in the United States. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 3432-8. PMID 23960185 DOI: 10.1200/JCO.2013.49.4823  0.2
2011 Biswas S, Nyman JS, Alvarez J, Chakrabarti A, Ayres A, Sterling J, Edwards J, Rana T, Johnson R, Perrien DS, Lonning S, Shyr Y, Matrisian LM, Mundy GR. Anti-transforming growth factor ß antibody treatment rescues bone loss and prevents breast cancer metastasis to bone. Plos One. 6: e27090. PMID 22096521 DOI: 10.1371/journal.pone.0027090  0.2
2009 Cheever MA, Allison JP, Ferris AS, Finn OJ, Hastings BM, Hecht TT, Mellman I, Prindiville SA, Viner JL, Weiner LM, Matrisian LM. The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 5323-37. PMID 19723653 DOI: 10.1158/1078-0432.CCR-09-0737  0.2
2008 Schilsky RL, Gordon G, Gilmer TM, Courtneidge SA, Matrisian LM, Grad O, Nelson WG. The Translational Research Working Group developmental pathway for anticancer agents (drugs or biologics). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 5685-91. PMID 18794076 DOI: 10.1158/1078-0432.CCR-08-1265  0.2
2008 Dorfman GS, Sullivan DC, Schnall MD, Matrisian LM. The Translational Research Working Group developmental pathway for image-based assessment modalities. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 5678-84. PMID 18794075 DOI: 10.1158/1078-0432.CCR-08-1264  0.2
2006 Lindsey ML, Escobar GP, Mukherjee R, Goshorn DK, Sheats NJ, Bruce JA, Mains IM, Hendrick JK, Hewett KW, Gourdie RG, Matrisian LM, Spinale FG. Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction. Circulation. 113: 2919-28. PMID 16769909 DOI: 10.1161/CIRCULATIONAHA.106.612960  0.2
2006 Qin X, Corriere MA, Matrisian LM, Guzman RJ. Matrix metalloproteinase inhibition attenuates aortic calcification. Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 1510-6. PMID 16690876 DOI: 10.1161/01.ATV.0000225807.76419.a7  0.2
2006 Zhang W, Matrisian LM, Holmbeck K, Vick CC, Rosenthal EL. Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo. Bmc Cancer. 6: 52. PMID 16515711 DOI: 10.1186/1471-2407-6-52  0.2
2004 DeClerck YA, Mercurio AM, Stack MS, Chapman HA, Zutter MM, Muschel RJ, Raz A, Matrisian LM, Sloane BF, Noel A, Hendrix MJ, Coussens L, Padarathsingh M. Proteases, extracellular matrix, and cancer: a workshop of the path B study section. The American Journal of Pathology. 164: 1131-9. PMID 15039201 DOI: 10.1016/S0002-9440(10)63200-2  0.2
2003 Filippov S, Caras I, Murray R, Matrisian LM, Chapman HA, Shapiro S, Weiss SJ. Matrilysin-dependent elastolysis by human macrophages. The Journal of Experimental Medicine. 198: 925-35. PMID 12963695 DOI: 10.1084/jem.20030626  0.2
2002 Newell KJ, Matrisian LM, Driman DK. Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis. Molecular Carcinogenesis. 34: 59-63. PMID 12112311 DOI: 10.1002/mc.10049  0.2
2012 Li X, Sterling JA, Fan KH, Vessella RL, Shyr Y, Hayward SW, Matrisian LM, Bhowmick NA. Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions. Molecular Cancer Research : McR. 10: 494-503. PMID 22290877 DOI: 10.1158/1541-7786.MCR-11-0506  0.16
2010 Bruni-Cardoso A, Lynch CC, Rosa-Ribeiro R, Matrisian LM, Carvalho HF. MMP-2 contributes to the development of the mouse ventral prostate by impacting epithelial growth and morphogenesis. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 239: 2386-92. PMID 20839326 DOI: 10.1002/dvdy.22382  0.16
2009 Thiolloy S, Halpern J, Holt GE, Schwartz HS, Mundy GR, Matrisian LM, Lynch CC. Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis. Cancer Research. 69: 6747-55. PMID 19679556 DOI: 10.1158/0008-5472.CAN-08-3949  0.16
2007 Martin MD, Matrisian LM. The other side of MMPs: protective roles in tumor progression. Cancer Metastasis Reviews. 26: 717-24. PMID 17717634 DOI: 10.1007/s10555-007-9089-4  0.16
2004 Lynch CC, Crawford HC, Matrisian LM, McDonnell S. Epidermal growth factor upregulates matrix metalloproteinase-7 expression through activation of PEA3 transcription factors. International Journal of Oncology. 24: 1565-72. PMID 15138601  0.16
2002 Lynch CC, Matrisian LM. Matrix metalloproteinases in tumor-host cell communication. Differentiation; Research in Biological Diversity. 70: 561-73. PMID 12492497 DOI: 10.1046/j.1432-0436.2002.700909.x  0.16
2003 Crawford HC, Krishna US, Israel DA, Matrisian LM, Washington MK, Peek RM. Helicobacter pylori strain-selective induction of matrix metalloproteinase-7 in vitro and within gastric mucosa. Gastroenterology. 125: 1125-36. PMID 14517796 DOI: 10.1016/S0016-5085(03)01206-X  0.08
2003 Rivat C, Le Floch N, Sabbah M, Teyrol I, Redeuilh G, Bruyneel E, Mareel M, Matrisian LM, Crawford HC, Gespach C, Attoub S. Synergistic cooperation between the AP-1 and LEF-1 transcription factors in activation of the matrilysin promoter by the src oncogene: implications in cellular invasion. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 17: 1721-3. PMID 12958188 DOI: 10.1096/fj.03-0132fje  0.08
2002 Crawford HC, Scoggins CR, Washington MK, Matrisian LM, Leach SD. Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas. The Journal of Clinical Investigation. 109: 1437-44. PMID 12045257 DOI: 10.1172/JCI15051  0.08
2014 Seeley EH, Wilson KJ, Yankeelov TE, Johnson RW, Gore JC, Caprioli RM, Matrisian LM, Sterling JA. Co-registration of multi-modality imaging allows for comprehensive analysis of tumor-induced bone disease. Bone. 61: 208-16. PMID 24487126 DOI: 10.1016/j.bone.2014.01.017  0.04
2008 Macias-Perez I, Borza C, Chen X, Yan X, Ibanez R, Mernaugh G, Matrisian LM, Zent R, Pozzi A. Loss of integrin alpha1beta1 ameliorates Kras-induced lung cancer. Cancer Research. 68: 6127-35. PMID 18676835 DOI: 10.1158/0008-5472.CAN-08-1395  0.04
2020 Pishvaian MJ, Blais EM, Brody JR, Lyons E, DeArbeloa P, Hendifar A, Mikhail S, Chung V, Sahai V, Sohal DPS, Bellakbira S, Thach D, Rahib L, Madhavan S, Matrisian LM, et al. Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial. The Lancet. Oncology. PMID 32135080 DOI: 10.1016/S1470-2045(20)30074-7  0.01
2019 Brar G, Blais EM, Joseph Bender R, Brody JR, Sohal D, Madhavan S, Picozzi VJ, Hendifar AE, Chung VM, Halverson D, Mikhail S, Matrisian LM, Rahib L, Petricoin E, Pishvaian MJ. Multi-omic molecular comparison of primary versus metastatic pancreatic tumours. British Journal of Cancer. PMID 31292535 DOI: 10.1038/s41416-019-0507-5  0.01
2018 Hendifar AE, Petzel MQB, Zimmers TA, Denlinger CS, Matrisian LM, Picozzi VJ, Rahib L. Pancreas Cancer-Associated Weight Loss. The Oncologist. PMID 30591550 DOI: 10.1634/theoncologist.2018-0266  0.01
2018 Pishvaian MJ, Bender RJ, Halverson D, Rahib L, Hendifar AE, Mikhail S, Chung V, Picozzi VJ, Sohal D, Blais EM, Mason K, Lyons EE, Matrisian LM, Brody JR, Madhavan S, et al. Molecular Profiling of Pancreatic Cancer Patients: Initial Results from the Know Your Tumor Initiative. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29954777 DOI: 10.1158/1078-0432.CCR-18-0531  0.01
2018 Van Sciver RE, Lee MP, Lee CD, Lafever AC, Svyatova E, Kanda K, Colliver AL, Siewertsz van Reesema LL, Tang-Tan AM, Zheleva V, Bwayi MN, Bian M, Schmidt RL, Matrisian LM, Petersen GM, et al. A New Strategy to Control and Eradicate "Undruggable" Oncogenic K-RAS-Driven Pancreatic Cancer: Molecular Insights and Core Principles Learned from Developmental and Evolutionary Biology. Cancers. 10. PMID 29757973 DOI: 10.3390/cancers10050142  0.01
2017 Pishvaian MJ, Joseph Bender R, Matrisian LM, Rahib L, Hendifar A, Hoos WA, Mikhail S, Chung V, Picozzi V, Heartwell C, Mason K, Varieur K, Aberra M, Madhavan S, Petricoin E, et al. A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative. Oncotarget. 8: 83446-83456. PMID 29137355 DOI: 10.18632/oncotarget.13225  0.01
2016 Pishvaian MJ, Bender RJ, Matrisian LM, Rahib L, Hendifar A, Hoos WA, Mikhail S, Chung V, Picozzi V, Heartwell C, Mason K, Varieur K, Aberra M, Madhavan S, Petricoin E, et al. A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative. Oncotarget. PMID 27833075 DOI: 10.18632/oncotarget.13225  0.01
2016 Brody JR, Yabar CS, Zarei M, Bender J, Matrisian LM, Rahib L, Heartwell C, Mason K, Yeo CJ, Peiper SC, Jiang W, Varieur K, Madhavan S, Petricoin E, Fortuna D, et al. Identification of a novel metabolic-related mutation (IDH1) in metastatic pancreatic cancer. Cancer Biology & Therapy. 0. PMID 27466707 DOI: 10.1080/15384047.2016.1210743  0.01
2016 Rahib L, Fleshman JM, Matrisian LM, Berlin JD. Evaluation of Pancreatic Cancer Clinical Trials and Benchmarks for Clinically Meaningful Future Trials: A Systematic Review. Jama Oncology. PMID 27270617 DOI: 10.1001/jamaoncol.2016.0585  0.01
2016 Matrisian LM, Berlin JD. The Past, Present, and Future of Pancreatic Cancer Clinical Trials. American Society of Clinical Oncology Educational Book / Asco. American Society of Clinical Oncology. Meeting. 35: e205-15. PMID 27249725 DOI: 10.14694/EDBK_159117  0.01
2011 Johnson RW, Nguyen MP, Padalecki SS, Grubbs BG, Merkel AR, Oyajobi BO, Matrisian LM, Mundy GR, Sterling JA. TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling. Cancer Research. 71: 822-31. PMID 21189326 DOI: 10.1158/0008-5472.CAN-10-2993  0.01
2009 Steeg PS, Anderson RL, Bar-Eli M, Chambers AF, Eccles SA, Hunter K, Itoh K, Kang Y, Matrisian LM, Sleeman JP, Theodorescu D, Thompson EW, Welch DR. An open letter to the FDA and other regulatory agencies: Preclinical drug development must consider the impact on metastasis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4529. PMID 25278743 DOI: 10.1158/1078-0432.CCR-09-1363  0.01
2008 Dorfman GS, Lawrence TS, Matrisian LM. The Translational Research Working Group developmental pathway for interventive devices. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 5700-6. PMID 18794078 DOI: 10.1158/1078-0432.CCR-08-1263  0.01
2008 Hawk ET, Matrisian LM, Nelson WG, Dorfman GS, Stevens L, Kwok J, Viner J, Hautala J, Grad O. The Translational Research Working Group developmental pathways: introduction and overview. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 5664-71. PMID 18612047 DOI: 10.1158/1078-0432.CCR-08-1268  0.01
2008 Yang L, Huang J, Ren X, Gorska AE, Chytil A, Aakre M, Carbone DP, Matrisian LM, Richmond A, Lin PC, Moses HL. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell. 13: 23-35. PMID 18167337 DOI: 10.1016/j.ccr.2007.12.004  0.01
2007 López-Otín C, Matrisian LM. Emerging roles of proteases in tumour suppression. Nature Reviews. Cancer. 7: 800-8. PMID 17851543 DOI: 10.1038/nrc2228  0.01
2007 DeBusk L, Russell AJ, Imai K, Matrisian LM. In the forefront of basic and translational cancer research: Seventh Joint Conference of the American Association for Cancer Research and the Japanese Cancer Association. Cancer Research. 67: 4556-9. PMID 17510381 DOI: 10.1158/0008-5472.CAN-07-1102  0.01
2006 Taylor JL, Hattle JM, Dreitz SA, Troudt JM, Izzo LS, Basaraba RJ, Orme IM, Matrisian LM, Izzo AA. Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection. Infection and Immunity. 74: 6135-44. PMID 16982845 DOI: 10.1128/IAI.02048-05  0.01
2006 Rosenthal EL, Matrisian LM. Matrix metalloproteases in head and neck cancer. Head & Neck. 28: 639-48. PMID 16470875 DOI: 10.1002/hed.20365  0.01
2004 Kundranda MN, Ray S, Saria M, Friedman D, Matrisian LM, Lukyanov P, Ochieng J. Annexins expressed on the cell surface serve as receptors for adhesion to immobilized fetuin-A. Biochimica Et Biophysica Acta. 1693: 111-23. PMID 15313013 DOI: 10.1016/j.bbamcr.2004.06.005  0.01
2003 Matrisian LM, Sledge GW, Mohla S. Extracellular proteolysis and cancer: meeting summary and future directions. Cancer Research. 63: 6105-9. PMID 14559785  0.01
2003 Kure T, Chang JH, Kato T, Hernández-Quintela E, Ye H, Lu PC, Matrisian LM, Gatinel D, Shapiro S, Gosheh F, Azar DT, Gosheh F. Corneal neovascularization after excimer keratectomy wounds in matrilysin-deficient mice. Investigative Ophthalmology & Visual Science. 44: 137-44. PMID 12506066  0.01
2002 Cunha GR, Matrisian LM. It's not my fault, blame it on my microenvironment. Differentiation; Research in Biological Diversity. 70: 469-72. PMID 12492489 DOI: 10.1046/j.1432-0436.2002.700901.x  0.01
2002 Brinckerhoff CE, Matrisian LM. Matrix metalloproteinases: a tail of a frog that became a prince. Nature Reviews. Molecular Cell Biology. 3: 207-14. PMID 11994741 DOI: 10.1038/nrm763  0.01
Hide low-probability matches.